Pulse Biosciences, Inc.

US$53.29As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:PLSEHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR 24.11%
Div yield —
ROE (60.61%)
Medical Instruments & Supplies
Beta (5Y) 1.64
PE TTM —
TSR TTM 214.77%
Mkt cap US$3.919B
ROIC (37.68%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$59
11.61%
124.56%
Hold 1|4|2|1|10
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.84
0.88
0.97
0.93
23.56%
29.97%
39.95%
21.64%
Revenue$M
221.2
231.5
239.2
247.5
2.85%
7.36%
6.63%
9.82%
Peers (US$3.919B)
Cap (US$)
PE
4.304B
71.81x
4.036B
6.541x
3.893B
—
Capital
TTM
5Y
10Y
Leveragex
0.605
0.027
0.024
EBIT/Intx
1.959
0.238
0.290
Own earn%
(0.13)
(67.50)
(68.71)
Sh yield%
26.29
27.28
27.25
Owners
Insiders/Inst%
12.04
20.40
Short interest%
1.02
SBC / revenue%
1.55
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
14
Op margin range%
6–12
$1 testx
0.2
Incr. ROIC%
3